# FDA Inspection 1050363 - Vitalant - April 05, 2018

Source: https://www.keypedia.com/records/fda_inspections/vitalant/3a388f1f-9f6c-4ec0-b2d3-33089c9cc50f
Source feed: FDA_Inspections

> FDA Inspection 1050363 for Vitalant on April 05, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050363
- Company Name: Vitalant
- Inspection Date: 2018-04-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1266226 - 2025-04-02](https://www.keypedia.com/records/fda_inspections/vitalant/3c3b626e-7c26-4cca-8493-1ef0996ee93d)
- [FDA Inspection 1266226 - 2025-04-02](https://www.keypedia.com/records/fda_inspections/vitalant/c30a33f0-c90b-4b81-8320-3181c99a95ce)
- [FDA Inspection 1209112 - 2023-06-21](https://www.keypedia.com/records/fda_inspections/vitalant/0f1f8608-47e3-431c-bde6-3c36f37270a5)
- [FDA Inspection 965009 - 2016-04-08](https://www.keypedia.com/records/fda_inspections/vitalant/f0d52bce-9709-4b49-93a1-b57e0e6e221c)
- [FDA Inspection 903137 - 2014-10-31](https://www.keypedia.com/records/fda_inspections/vitalant/240d7629-403d-4eec-91f4-34e3c310e61f)

Company: https://www.keypedia.com/companies/vitalant/9c132dc0-3c7e-4b96-ab37-2f812ff9ed50

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d